Gilead Sciences, Inc.

Insider Reports History

Entity
Company
Location
333 Lakeside Dr, Foster City, California
Signature
Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gilead Sciences, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. 10%+ Owner Common Stock 30.1M $631M $21.00 Jan 29, 2024 Direct
Arcellx, Inc. 10%+ Owner Common Stock 6.72M $371M $55.27 Dec 28, 2023 Direct
ASSEMBLY BIOSCIENCES, INC. 10%+ Owner Common Stock 1.27M $19M $14.93 Jun 17, 2024 Direct
LEAP THERAPEUTICS, INC. 10%+ Owner Common Stock 5.32M $15.2M $2.85 Apr 10, 2024 Direct
HOOKIPA Pharma Inc. 10%+ Owner Common Stock 18.8M $13.6M $0.73 Dec 20, 2023 Direct
Allovir, Inc. 10%+ Owner Common Stock 16.6M $11.2M $0.67 Jun 27, 2023 Direct
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 7.35M $5.58M $0.76 Apr 2, 2024 Direct
Xilio Therapeutics, Inc. 10%+ Owner Prefunded Warrants (right to buy) 3.88M $2.95M $0.76 Apr 2, 2024 Direct
Kyverna Therapeutics, Inc. 10%+ Owner Common Stock 4.13M Feb 12, 2024 Direct
ASSEMBLY BIOSCIENCES, INC. 10%+ Owner Warrant to purchase Common Stock 180K Jun 17, 2024 Direct
Kyverna Therapeutics, Inc. 10%+ Owner Series A-2 Convertible Preferred Stock 0 Feb 12, 2024 Direct
Kyverna Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Feb 12, 2024 Direct

Insider Reports Filed by Gilead Sciences, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ASMB ASSEMBLY BIOSCIENCES, INC. Jun 17, 2024 2 $0 4 Jun 20, 2024 10%+ Owner
LPTX LEAP THERAPEUTICS, INC. Apr 10, 2024 0 $0 3 Apr 19, 2024 10%+ Owner
XLO Xilio Therapeutics, Inc. Apr 2, 2024 2 $3.32M 4 Apr 3, 2024 10%+ Owner
XLO Xilio Therapeutics, Inc. Mar 27, 2024 0 $0 3 Apr 3, 2024 10%+ Owner
KYTX Kyverna Therapeutics, Inc. Feb 12, 2024 4 $20M 4 Feb 13, 2024 10%+ Owner
KYTX Kyverna Therapeutics, Inc. Feb 7, 2024 0 $0 3 Feb 7, 2024 10%+ Owner
RCUS Arcus Biosciences, Inc. Jan 29, 2024 1 $320M 4 Jan 31, 2024 10%+ Owner
ACLX Arcellx, Inc. Dec 28, 2023 0 $0 3 Dec 28, 2023 10%+ Owner
HOOK HOOKIPA Pharma Inc. Dec 20, 2023 0 $0 3 Dec 22, 2023 10%+ Owner
ASMB ASSEMBLY BIOSCIENCES, INC. Oct 16, 2023 0 $0 3 Oct 25, 2023 10%+ Owner
RCUS Arcus Biosciences, Inc. Jun 28, 2023 1 $19.5M 4 Jun 30, 2023 10%+ Owner
ALVR Allovir, Inc. Jun 27, 2023 1 $11M 4 Jun 28, 2023 10%+ Owner
ALVR Allovir, Inc. Jul 28, 2022 0 $0 3 Aug 5, 2022 10%+ Owner
HOOK HOOKIPA Pharma Inc. Feb 15, 2022 0 $0 3 Feb 17, 2022 10%+ Owner